致幻剂研究人员对致幻剂的亲身体验,他们与致幻剂观点的联系,以及对位置性的反思。

IF 3.3 3区 医学 Q2 NEUROSCIENCES
Jussi Jylkkä, Aila Mustamo
{"title":"致幻剂研究人员对致幻剂的亲身体验,他们与致幻剂观点的联系,以及对位置性的反思。","authors":"Jussi Jylkkä, Aila Mustamo","doi":"10.1007/s00213-025-06871-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Anecdotal evidence suggests that psychedelic researchers often have personal experiences with psychedelic substances. While such experiences may benefit research, concerns have been raised about potential biases and \"excessive enthusiasm.\" However, the prevalence of personal experiences, their perceived relevance, and their association with opinions about psychedelics remain underexplored.</p><p><strong>Objectives: </strong>This study aimed to investigate how common personal psychedelic experiences are among psychedelic researchers, their perceived relevance to research, and whether personal use is associated with opinions about psychedelics.</p><p><strong>Methods: </strong>Participants (N = 111) conducting psychedelic research in academic settings were recruited. Data were collected on personal experiences, their perceived relevance, and opinions about psychedelics. Regression analyses examined associations between personal use and opinions.</p><p><strong>Results: </strong>Most respondents (85%) reported personal experiences with classic psychedelics. On average, they saw personal experience as beneficial for research, but also as potential source of bias. They acknowledged the importance of self-reflection and the need to disclose personal experiences, but found disclosure challenging in practice. Personal use predicted more positive opinions about psychedelics' potential to improve well-being, transform society, address the ecological crisis, and answer spiritual questions (regression βs = 0.3 - 0.5, ps < 0.01).</p><p><strong>Conclusions: </strong>The findings highlight the prevalence of personal psychedelic experiences among this sample of researchers and their influence on research interests and opinions. The results underscore the need for open discussion and reflection. Future studies should explore whether the observed associations reflect causal relationships or potential biases.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Psychedelic researchers' own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality.\",\"authors\":\"Jussi Jylkkä, Aila Mustamo\",\"doi\":\"10.1007/s00213-025-06871-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>Anecdotal evidence suggests that psychedelic researchers often have personal experiences with psychedelic substances. While such experiences may benefit research, concerns have been raised about potential biases and \\\"excessive enthusiasm.\\\" However, the prevalence of personal experiences, their perceived relevance, and their association with opinions about psychedelics remain underexplored.</p><p><strong>Objectives: </strong>This study aimed to investigate how common personal psychedelic experiences are among psychedelic researchers, their perceived relevance to research, and whether personal use is associated with opinions about psychedelics.</p><p><strong>Methods: </strong>Participants (N = 111) conducting psychedelic research in academic settings were recruited. Data were collected on personal experiences, their perceived relevance, and opinions about psychedelics. Regression analyses examined associations between personal use and opinions.</p><p><strong>Results: </strong>Most respondents (85%) reported personal experiences with classic psychedelics. On average, they saw personal experience as beneficial for research, but also as potential source of bias. They acknowledged the importance of self-reflection and the need to disclose personal experiences, but found disclosure challenging in practice. Personal use predicted more positive opinions about psychedelics' potential to improve well-being, transform society, address the ecological crisis, and answer spiritual questions (regression βs = 0.3 - 0.5, ps < 0.01).</p><p><strong>Conclusions: </strong>The findings highlight the prevalence of personal psychedelic experiences among this sample of researchers and their influence on research interests and opinions. The results underscore the need for open discussion and reflection. Future studies should explore whether the observed associations reflect causal relationships or potential biases.</p>\",\"PeriodicalId\":20783,\"journal\":{\"name\":\"Psychopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-08-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00213-025-06871-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06871-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

理由:坊间证据表明,迷幻药研究人员经常有使用迷幻药物的个人经历。虽然这样的经历可能有利于研究,但人们也提出了对潜在偏见和“过度热情”的担忧。然而,个人经历的普遍性、它们的感知相关性以及它们与迷幻药观点的联系仍未得到充分探讨。目的:本研究旨在调查致幻剂研究者中个人致幻剂体验的普遍程度,他们与研究的感知相关性,以及个人使用是否与致幻剂的观点有关。方法:招募在学术环境下进行致幻剂研究的参与者(N = 111)。数据收集了个人经历、感知到的相关性以及对迷幻药的看法。回归分析检验了个人使用和意见之间的联系。结果:大多数受访者(85%)报告了经典迷幻药的个人经历。平均而言,他们认为个人经历对研究有益,但也可能成为偏见的来源。他们承认自我反省的重要性和披露个人经历的必要性,但发现披露在实践中具有挑战性。个人使用迷幻药预测了迷幻药在改善福祉、改变社会、解决生态危机和回答精神问题方面的潜力更积极的看法(回归s = 0.3 - 0.5, ps)。结论:研究结果突出了个人迷幻体验在该样本研究人员中的流行程度及其对研究兴趣和观点的影响。研究结果强调了公开讨论和反思的必要性。未来的研究应该探索观察到的关联是否反映了因果关系或潜在的偏差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Psychedelic researchers' own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality.

Rationale: Anecdotal evidence suggests that psychedelic researchers often have personal experiences with psychedelic substances. While such experiences may benefit research, concerns have been raised about potential biases and "excessive enthusiasm." However, the prevalence of personal experiences, their perceived relevance, and their association with opinions about psychedelics remain underexplored.

Objectives: This study aimed to investigate how common personal psychedelic experiences are among psychedelic researchers, their perceived relevance to research, and whether personal use is associated with opinions about psychedelics.

Methods: Participants (N = 111) conducting psychedelic research in academic settings were recruited. Data were collected on personal experiences, their perceived relevance, and opinions about psychedelics. Regression analyses examined associations between personal use and opinions.

Results: Most respondents (85%) reported personal experiences with classic psychedelics. On average, they saw personal experience as beneficial for research, but also as potential source of bias. They acknowledged the importance of self-reflection and the need to disclose personal experiences, but found disclosure challenging in practice. Personal use predicted more positive opinions about psychedelics' potential to improve well-being, transform society, address the ecological crisis, and answer spiritual questions (regression βs = 0.3 - 0.5, ps < 0.01).

Conclusions: The findings highlight the prevalence of personal psychedelic experiences among this sample of researchers and their influence on research interests and opinions. The results underscore the need for open discussion and reflection. Future studies should explore whether the observed associations reflect causal relationships or potential biases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychopharmacology
Psychopharmacology 医学-精神病学
CiteScore
7.10
自引率
5.90%
发文量
257
审稿时长
2-4 weeks
期刊介绍: Official Journal of the European Behavioural Pharmacology Society (EBPS) Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields: Human Psychopharmacology: Experimental This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered. Human Psychopharmacology: Clinical and Translational This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects. Preclinical psychopharmacology: Behavioral and Neural This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels. Preclinical Psychopharmacology: Translational This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways. Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信